AQP9 activators belong to a specific class of chemical compounds designed to modulate the activity of the Aquaporin-9 (AQP9) protein. AQP9 is a member of the aquaporin family, which are integral membrane proteins known for their role in facilitating the transport of water and other small solutes across cell membranes. AQP9, in particular, is primarily expressed in tissues such as the liver, adipose tissue, and leukocytes, where it plays a vital role in regulating water and glycerol transport. AQP9 activators are designed to interact with AQP9, influencing its function and potentially enhancing the movement of water and glycerol across cell membranes. Chemically, AQP9 activators are designed to bind to specific sites on the AQP9 protein, inducing conformational changes that can alter its permeability to water and glycerol. By doing so, these activators may facilitate the movement of these molecules across cellular membranes, which can have various physiological implications depending on the tissue or cell type. This class of compounds is of particular interest in the study of water and glycerol homeostasis, as well as in understanding the regulatory mechanisms governing osmoregulation and metabolic processes in cells and tissues where AQP9 is expressed.
In summary, AQP9 activators are a specialized group of chemical compounds aimed at modulating the activity of the AQP9 protein, an aquaporin involved in the transport of water and glycerol across cell membranes. These activators interact with AQP9 to enhance the movement of water and glycerol in specific tissues, with implications for cellular osmoregulation and metabolic processes. Their chemical design allows for targeted interactions with AQP9, shedding light on the intricate mechanisms that govern water and solute transport in various biological contexts.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Enhances cAMP levels, potentially affecting AQP9 regulation indirectly through cAMP-dependent pathways. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A non-specific phosphodiesterase inhibitor, increases cAMP and cGMP levels, which may influence AQP9. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Can modulate AQP9 expression, particularly in liver and adipose tissues, by influencing glucose metabolism. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
An antidiabetic drug that may affect AQP9 expression by altering cellular glucose and lipid metabolism. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
A glucocorticoid that might influence AQP9 expression through glucocorticoid-responsive elements. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Known to regulate gene expression; could affect AQP9 expression via retinoid-responsive elements. | ||||||
L-3,3′,5-Triiodothyronine, Sodium Salt | 55-06-1 | sc-205725 | 250 mg | $115.00 | ||
Thyroid hormone that can influence AQP9 expression, particularly in thyroid-responsive tissues. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Might affect AQP9 expression through estrogen receptor-mediated pathways, especially in gender-specific tissues. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
A polyphenol that might modulate AQP9 expression via its effects on cellular oxidative stress and inflammation pathways. | ||||||